Fluzone (Influenza Vaccine)

Manufacturer
Bamboo US BidCo LLC
Effective date
2026-07-01
Label type
VACCINE LABEL
Version
1
Source
weekly-update
Hydrated at
2026-07-17 21:42:26

Label at a glance#

ProductFLUZONE TRIVALENT NORTHERN HEMISPHERE
Active ingredientINFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)
Label structure1 sections

Label contents#

Full prescribing information#

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Package

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

2026-2027

Formula

Influenza Vaccine
Fluzone ®

Rx only

For Intramuscular Use
For 6 months of age and older
10 single-dose prefilled syringes 0.5 mL each

sanofi

00

3333

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeData Matrix6564image 2.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83703-08783703-087-88, 83703-087-50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103914Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone QuadrivalentInfluenza Virus Vaccine351(a)Rx2026-09-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.